Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses —197.52 K—180.46 K — Research & development ———— — Operating income —-197.52 K—-180.46 K — Non-Operating Income, Total —1.27 M—3.07 M — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses —1.27 M—3.07 M — Unusual income/expense ———— — Pretax income —1.07 M—2.89 M — Equity in earnings ———— — Taxes —0—0 — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations —1.07 M—2.89 M — Discontinued operations ———— — Net income —1.07 M—2.89 M — Dilution adjustment —29.25 M—3.07 M — Preferred dividends —29.29 M—3.07 M — Diluted net income available to common stockholders —1.03 M—2.89 M — Basic earnings per share (Basic EPS) —0.12—0.14 — Diluted earnings per share (Diluted EPS) —0.12—0.14 — Average basic shares outstanding 7.5 M17.7 M28.84 M43.13 M — Diluted shares outstanding 7.5 M18.49 M29.19 M43.13 M — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —